Sales and Marketing
News/ News/ News/ Oncology/ Sales and Marketing
FDA clears new first-line use for Servier’s Tibsovo in AML
Phil Taylor
acute myeloid leukaemia, Oncology, Servier, targeted oncology, Tibsovo
0 Comment
News/ News/ Sales and Marketing
Lilly sets aside $2.1bn for domestic investments
Phil Taylor
Eli Lilly, Indiana, investment, manufacturing
0 Comment
Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
Top 5 takeaways from international hybrid and virtual meeting guidance for pharma
Amanda Barrell
EFPIA, IFPMA, pharma, PhRMA, remote meetings, virtual meetings
0 Comment
Market Access/ News/ News/ News/ Sales and Marketing
Pfizer makes non-profit pledge for low-income nations
Phil Taylor
Comirnaty, developing world, market access, Paxlovid, Pfizer, pricing
0 Comment
News/ News/ Sales and Marketing
Pay deal averts strike action at GSK’s UK sites
Phil Taylor
GlaxoSmithKline, manufacturing, remuneration, strike
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis
Find your inner data and take precision marketing to the next level
mike.hammerton@pharmaphorum.com
clinical trials, data, HCP, precision marketing, Thomas Kurian, Treasure Data
0 Comment
Market Access/ News/ News/ News/ Sales and Marketing
Dupixent claims new territory in eosinophilic oesophagitis
Phil Taylor
Dupixent, eosinophilic oesophagitis, Immunology and inflammation, Regeneron, regulatory approval, Sanofi
0 Comment
News/ News/ Sales and Marketing
Pharma bad boy Martin Shkreli is on the streets again
Phil Taylor
drug prices, Legal, Martin Shkreli, price gouging
0 Comment